# DallahHealth

> DallahHealth is a Riyadh-based, publicly listed healthcare group operating hospitals, outpatient clinics and homecare services in Saudi Arabia. It also manufactures and distributes pharmaceuticals, provides hospital facilities support and invests in healthcare businesses. The group recorded approximately 3.8 million patient visits and SAR 4.067 billion in revenue in 2025.

- **Founded:** 1994
- **Headquarters:** Riyadh, Saudi Arabia
- **Founders:** Saleh Abdullah Kamel (Original owner of Dallah Hospital, the 1987 predecessor business, as documented in the shareholder circular)
- **Products:** Dallah Hospitals, Dallah Clinics, Dallah Home Care, Dallah Pharma, Afyaa Al Nakheel
- **Notable:** Saudi Exchange main-market listing in 2012., Approximately 3.8 million patient visits in 2025, up from 2.8 million in 2024., Revenue reached SAR 4.067 billion in 2025, up 26.9%.

## Products & services

- **Dallah Hospitals** — Inpatient, outpatient, diagnostic, surgical and specialist care, with hospital roots at Al Nakheel in Riyadh.
- **Dallah Clinics** — Neighborhood outpatient and specialty clinics, including Al Ared, Qurtabah, Al Yarmouk, Al Salam and Consulting Clinics.
- **Dallah Home Care** — Physician-supervised home nursing, physiotherapy, rehabilitation, chronic care, palliative care, teleconsultations and remote monitoring.
- **Dallah Pharma** — Pharmaceutical manufacturing, distribution and marketing, medical supplies, devices, consumables and nutritional supplements.
- **Afyaa Al Nakheel** — Non-clinical hospital facilities support, infrastructure maintenance, safety systems and risk audits for group and third-party institutions.
- **Healthcare investments** — Holdings in healthcare operators and related funds, including Makkah Medical Center and International Medical Center in Jeddah.

## Achievements

- Saudi Exchange main-market listing in 2012.
- Approximately 3.8 million patient visits in 2025, up from 2.8 million in 2024.
- Revenue reached SAR 4.067 billion in 2025, up 26.9%.
- Reported Al Khobar quarterly result improved from a SAR 34 million loss in Q4 2024 to a SAR 5 million profit in Q4 2025.
- Dallah reports that Al Nakheel became the first hospital outside the United States to hold 12 SRC surgical centers of excellence under one roof.
- Dallah announced 40th place overall and first in healthcare in TIME and Statista’s 2026 Gulf growth ranking.

## Latest updates

- **2026-09** — Muteab Abdullah Altukeas assumed the CEO role effective 1 September 2026; the company’s current executive profile identifies him as CEO.
- **2026-08** — H1 revenue rose 11.9% to SAR 2,121.16 million; Q2 attributable net profit fell 19.5% to SAR 100.01 million. The company reported receiving SAR 466.7 million from its Al-Fagih stake sale in July and intended to apply most proceeds to financing obligations.
- **2026-04** — Dallah announced its inclusion in TIME and Statista’s 2026 ranking of the Gulf’s fastest-growing companies.
- **2026-03** — 2025 annual results reported SAR 4.067 billion revenue and SAR 538 million attributable net profit.

## Links

- Website: https://www.dallahhealth.com/
- LinkedIn: https://www.linkedin.com/company/dallahhealth
- Twitter/X: https://x.com/dallahhealth
- YouTube: https://www.youtube.com/user/DallahHospitalKSA
- Instagram: https://www.instagram.com/dallahhospitals/
- Facebook: https://www.facebook.com/dallahhospitals

---

Profile page: https://yespress.io/dallahhealth
Published by YesPress — https://yespress.io
Last updated: 2026-10-22